In mesenchymal cells, we found an enrichment of Galectin-1 (LGALS1), which has been associated with EMT in hepatocellular carcinoma, and an increase in genes associated with the biosynthetic pathway of gangliosides, which has been previously reported for ovarian cancer.45 This evidence concerns the gene LGALS1 and ovarian cancer.